11
Participants
Start Date
July 31, 2015
Primary Completion Date
June 27, 2018
Study Completion Date
July 30, 2018
estradiol 0.045 mg/levonorgestrel 0.015mg
Massachusetts General Hospital, Boston
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Massachusetts General Hospital
OTHER